SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001096906-24-001225
Filing Date
2024-05-22
Accepted
2024-05-22 16:53:56
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A axim_10q.htm   iXBRL 10-Q/A 1213231
2 CERTIFICATION axim_ex311.htm EX-31.1 14751
3 CERTIFICATION axim_ex312.htm EX-31.2 14950
4 CERTIFICATION axim_ex321.htm EX-32.1 4548
5 CERTIFICATION axim_ex322.htm EX-32.2 3435
11 axim_10qimg2.jpg GRAPHIC 4918
  Complete submission text file 0001096906-24-001225.txt   6036103

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA axim-20240331.xsd EX-101.SCH 65176
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE axim-20240331_lab.xml EX-101.LAB 373591
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axim-20240331_cal.xml EX-101.CAL 52749
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axim-20240331_pre.xml EX-101.PRE 319047
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axim-20240331_def.xml EX-101.DEF 210327
75 EXTRACTED XBRL INSTANCE DOCUMENT axim_10q_htm.xml XML 811060
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54296 | Film No.: 24974126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)